Correlation Between Sonnet Biotherapeutics and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Ventyx Biosciences, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Ventyx Biosciences.
Diversification Opportunities for Sonnet Biotherapeutics and Ventyx Biosciences
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sonnet and Ventyx is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Ventyx Biosciences
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Ventyx Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 1.05 times less risky than Ventyx Biosciences. The stock trades about -0.08 of its potential returns per unit of risk. The Ventyx Biosciences is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 2,750 in Ventyx Biosciences on August 27, 2024 and sell it today you would lose (2,565) from holding Ventyx Biosciences or give up 93.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Ventyx Biosciences
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Ventyx Biosciences |
Sonnet Biotherapeutics and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Ventyx Biosciences
The main advantage of trading using opposite Sonnet Biotherapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Ventyx Biosciences vs. Capricor Therapeutics | Ventyx Biosciences vs. Soleno Therapeutics | Ventyx Biosciences vs. Bio Path Holdings | Ventyx Biosciences vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |